This is a type of birth defect in the brain where blood vessels connect directly between an artery and a vein, skipping the small capillaries. This connection is abnormal and can cause problems like headaches, seizures, or stroke. It's often called an AVM.
Every report comes from a Lived member, sent anonymously.
Have you had Radiosurgery for Intracranial Arteriovenous Malformation?
An intracranial arteriovenous malformation (AVM) is an abnormal tangle of blood vessels in the brain in which arteries connect directly to veins. Normally, blood flows from arteries into capillaries, tiny vessels that slow it down and deliver oxygen to brain tissue, before draining into veins. In an AVM the capillaries are missing, so fast, high-pressure arterial blood rushes straight into veins that are not built to handle it. That arrangement matters for two reasons. The strained vessel walls can weaken and tear, causing bleeding into the brain (a hemorrhage), which can lead to a stroke, lasting brain damage or death. Brain AVMs are an important cause of this kind of stroke in children and young adults. The abnormal flow can also starve or irritate nearby brain tissue, causing seizures, headaches, or problems that depend on where the AVM sits, such as weakness, numbness, vision changes or difficulty speaking. Brain AVMs are rare, and many cause few or no symptoms. Some are found by chance on a scan done for another reason; others first come to attention with a seizure or a bleed. An AVM is different from an aneurysm, which is a balloon-like bulge in a single artery wall, although aneurysms can form on the vessels feeding an AVM. It is also different from a cavernous malformation, a cluster of slow-flowing vessels that generally carries a lower risk of major bleeding.
Most brain AVMs are thought to form while blood vessels are developing before birth. Many people are born with one, although some appear shortly after birth or later in life. Nothing a person did causes an AVM. Research has found that many AVMs carry a genetic change, most often in a gene called KRAS, that arose only in the cells of the malformation itself rather than being inherited, and most brain AVMs do not run in families. A small share occur as part of inherited conditions. The best known is hereditary hemorrhagic telangiectasia (HHT), which also causes frequent nosebleeds and small red blood vessel spots on the skin, lips and inside the mouth. About 1 in 5 people with one common form of HHT has a brain AVM. A personal or family history of HHT is a reason to ask about screening and genetic counseling. Other features affect how likely an existing AVM is to bleed rather than whether one forms. An AVM that has already bled is more likely to bleed again, especially in the first year afterward. Drainage through deep or narrowed veins and aneurysms on the vessels around the AVM are also linked with a higher risk. Pregnancy appears to raise the chance of bleeding, mainly because blood volume and blood pressure increase.
Brain AVMs are found with imaging, either after symptoms such as a seizure or bleed, or by chance on a scan done for something else. A CT scan (computed tomography, a fast X-ray scan) is especially good at showing fresh bleeding, so it is often the first test in an emergency. MRI (magnetic resonance imaging) shows the surrounding brain in more detail, and MR or CT angiography adds pictures of the blood vessels. Catheter angiography gives the most accurate picture of an AVM. A thin tube is threaded from an artery in the groin or wrist into the arteries that supply the brain, and dye injected through it shows on X-rays which arteries feed the AVM, how fast blood moves through it and where it drains. That map shapes nearly every treatment decision. Specialists often describe an AVM with the Spetzler-Martin grade, a score from I to V built from three features: its size, whether it sits in or next to eloquent brain (areas that control movement, sensation, language or vision), and whether it drains into deep veins. Lower grades generally have better treatment outcomes, and higher grades carry more risk from treatment. The grade is a starting point rather than a verdict, especially for grade III AVMs, which vary widely. Occasionally a doctor can hear a whooshing sound over the head, called a bruit, caused by the rapid blood flow.
The goal of treatment is to remove or close off the AVM so it can no longer bleed, while protecting the brain around it. Whether that is worth the risk depends on whether the AVM has bled, its size and location, the person's age and health, and how each option fits. These decisions are best made with a team experienced in AVMs, usually including a neurosurgeon, an interventional neuroradiologist and a radiation specialist. Surgery (microsurgical resection) removes the AVM through an opening in the skull. When follow-up imaging confirms it is completely gone, the AVM is considered cured. Surgery suits AVMs that are relatively small and near the brain's surface; for deep AVMs or those in critical areas, the risk of new weakness, speech or vision problems is higher. Stereotactic radiosurgery, such as Gamma Knife, involves no incision. Many precisely aimed radiation beams meet at the AVM, usually in a single session, damaging the vessel walls so they gradually scar and close. It is often used for smaller AVMs in deep or critical locations. The trade-off is time: closure often takes around three years, the AVM can still bleed until it closes, and not every AVM closes completely. In reviews of small, low-grade AVMs, about 8 in 10 closed completely and about 6 in 100 people had a bleed during follow-up, though the studies behind these figures are of low quality. Radiation can also affect nearby brain tissue. Embolization uses a catheter threaded through the arteries to block feeding vessels with a glue-like material or coils, reducing flow through the AVM. It rarely cures an AVM on its own and is mainly used to make surgery or radiosurgery safer. For an AVM that has never bled, a procedure is not automatically the better choice. In the ARUBA trial, adults with unruptured AVMs who were managed with medicines and monitoring alone had fewer strokes or deaths over about four years than those who had procedures (about 3 versus 12 per 100 people each year). The trial was smaller than planned, and how the two approaches compare over decades is uncertain, so the decision remains individual. After an AVM has bled, the higher risk of another bleed makes treatment to remove or close it more often worthwhile. Medicines do not shrink or close an AVM, but they treat its effects. Anti-seizure medicines control seizures for many people, pain relievers help with headaches, and blood pressure is kept in a healthy range. Medicines aimed at the genetic changes found in AVMs are being studied but are not yet established treatment.
The outlook varies widely, because it depends on whether the AVM has bled, where it sits and how it is managed. Many people live for years with an AVM that never bleeds. For an untreated AVM that has not bled, the chance of bleeding is a few percent a year; people in the ARUBA observation group had a risk of about 1 to 3 percent each year. Because that yearly risk adds up over the decades ahead, age weighs heavily in decisions about whether to treat. Regular imaging is part of life with an AVM, whether it is being watched or has been treated. After surgery, angiography checks that it is fully removed. After radiosurgery, MRI and eventually angiography track whether it has closed, which can take several years. People who are being observed have periodic scans, and keeping blood pressure under control matters for everyone. After a bleed, recovery depends on the size and location of the hemorrhage. Some people recover well, while others are left with weakness, speech, vision or thinking problems and benefit from rehabilitation. Seizures, when they occur, are often well controlled with medicine. Pregnancy is possible with an AVM but deserves planning, because the rise in blood volume and blood pressure appears to increase the chance of bleeding. Talking with the AVM team and an obstetrician before or early in pregnancy helps plan monitoring and delivery.
If an AVM was found by chance, ask for a referral to a center experienced in AVMs to talk through whether to treat or observe it, and keep follow-up scans on schedule. Talk with your care team before a planned pregnancy. Contact your care team soon if seizures become more frequent or different, or if your headaches change in pattern. Call 911 for a sudden, severe headache (often described as the worst of your life), a first seizure, sudden weakness in an arm or leg, trouble speaking, or sudden problems with vision or balance. These can be signs that the AVM is bleeding, which needs emergency treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Intracranial Arteriovenous Malformation is like, what's helped you, or ask the community a question.